![](https://amcp.org/sites/default/files/styles/card_fullsize/public/images/Stock-biosimilars-biologic-vial.jpg.webp?itok=qx9N2zqC)
Press Release: Academy of Managed Care Pharmacy Kicks Off AMCP Nexus 2018: Preparing for the Next Generation of Care
Press Release: The Academy of Managed Care Pharmacy (AMCP) Foundation is delighted to announce that six student pharmacists from across the country recently completed summer internship programs organized by the Foundation and supported by Pfizer, Inc.
Press Release: The Academy of Managed Care Pharmacy (AMCP) Foundation is delighted to announce that two student pharmacists recently completed a summer internship organized by the Foundation and supported by Allergan Plc.
Press Release: The Academy of Managed Care Pharmacy (AMCP) Foundation is delighted to announce that two student pharmacists recently completed a summer internship organized by the Foundation and supported by Genentech, Inc.
Press Release: Evidence of ‘Nocebo’ Effect in Patients Taking Biosimilar Products is Unclear, According to Research in JMCP
Press Release: Health information technology (IT) should be the foundation of all business and clinical operations and not a secondary byproduct.
Press Release: Opioid Prescribing in Georgia Medicaid Program: Potentially Inappropriate Practices are Increasing, According to a Study in JMCP
Press Release: AMCP Urges FDA to Issue Final Guidance on Biosimilar Interchangeability Standards and Provide Education on Substituting Interchangeable Products
Press Release: AMCP Partnership Forum Examines Non-Traditional Payment and Benefit Models for High-Cost Pharmaceuticals
Press Release: AMCP Foundation Adds Two New Members to Board of Trustees
Press Release: As the Academy of Managed Care Pharmacy (AMCP) Foundation marks its 28th anniversary today, the organization celebrates another successful philanthropic effort from this spring.
Press Release: The Academy of Managed Care Pharmacy (AMCP) commends the U.S. Food and Drug Administration (FDA) for issuing final guidance that clarifies how manufacturers can communicate truthful and non-misleading information with payers across a product’s lifecycle.